Boothbay Fund Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Boothbay Fund Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-539,954	Closed	-$1.57M	–	2744
2022 Q1	$1.57M	Buy	539,954 +220,454	+69%	+$708K	0.04%	686
2021 Q4	$1.03M	Buy	+319,500	New	+$1.09M	0.02%	738
2021 Q3	–	Sell	-13,900	Closed	-$44K	–	2251
2021 Q2	$44K	Buy	+13,900	New	+$43.7K	﹤0.01%	1769
2016 Q4	–	Sell	-26,137	Closed	-$133K	–	983
2016 Q3	$133K	Buy	+26,137	New	+$156K	0.03%	607

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's ENZ Position: Q2 2022 in Review

Boothbay Fund Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2022, closing a stake of 539,954 shares — an estimated $1.57M sold.

Boothbay Fund Management first reported a position in ENZ in Q3 2016 and held it in 4 quarters. The position peaked at $1.57M in Q1 2022. 54 funds tracked by Wall St. Rank hold ENZ as of Q2 2022.

Boothbay Fund Management reported no remaining Enzo Biochem, Inc. position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 539,954 Enzo Biochem, Inc. shares in Q2 2022, an estimated $1.57M.
Boothbay Fund Management first reported a position in Enzo Biochem, Inc. in Q3 2016 and held it in 4 quarters.
Boothbay Fund Management's Enzo Biochem, Inc. position peaked at $1.57M in Q1 2022.
54 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.